Trial Profile
CEDARCURE SLIT-tablet special drug use surveillance
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2022
Price :
$35
*
At a glance
- Drugs Japanese cedar pollen allergy immunotherapy ALK Abello/Torii Pharmaceutical (Primary)
- Indications Seasonal allergic rhinitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Torii Pharmaceutical
- 28 Nov 2018 New trial record